Man­u­fac­tur­ing roundup: Teru­mo BCT part­ners with Bio­Bridge sub­sidiary to man­u­fac­ture cell and gene ther­a­pies; WuXi STA opens plant for HPA­PI pro­duc­tion

As the man­u­fac­tur­ing of cell and gene ther­a­pies is ramp­ing up and com­pa­nies are start­ing to in­vest in their man­u­fac­tur­ing ca­pa­bil­i­ties, Teru­mo Blood and Cell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.